Free Trial

Leap Therapeutics (LPTX) Competitors

Leap Therapeutics logo
$0.30 -0.01 (-4.00%)
Closing price 09/23/2025 04:00 PM Eastern
Extended Trading
$0.30 +0.00 (+0.20%)
As of 05:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LPTX vs. DTIL, AADI, FGEN, PEPG, EGRX, ANVS, ACRV, SCYX, RNXT, and OTLK

Should you be buying Leap Therapeutics stock or one of its competitors? The main competitors of Leap Therapeutics include Precision BioSciences (DTIL), Aadi Bioscience (AADI), FibroGen (FGEN), PepGen (PEPG), Eagle Pharmaceuticals (EGRX), Annovis Bio (ANVS), Acrivon Therapeutics (ACRV), SCYNEXIS (SCYX), RenovoRx (RNXT), and Oncobiologics (OTLK). These companies are all part of the "pharmaceutical products" industry.

Leap Therapeutics vs. Its Competitors

Precision BioSciences (NASDAQ:DTIL) and Leap Therapeutics (NASDAQ:LPTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Precision BioSciences presently has a consensus target price of $47.00, indicating a potential upside of 863.11%. Leap Therapeutics has a consensus target price of $3.38, indicating a potential upside of 1,042.52%. Given Leap Therapeutics' higher possible upside, analysts clearly believe Leap Therapeutics is more favorable than Precision BioSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision BioSciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Leap Therapeutics
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Precision BioSciences has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500. Comparatively, Leap Therapeutics has a beta of -0.21, indicating that its stock price is 121% less volatile than the S&P 500.

38.0% of Precision BioSciences shares are held by institutional investors. Comparatively, 30.5% of Leap Therapeutics shares are held by institutional investors. 4.0% of Precision BioSciences shares are held by company insiders. Comparatively, 7.5% of Leap Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Precision BioSciences has higher revenue and earnings than Leap Therapeutics. Precision BioSciences is trading at a lower price-to-earnings ratio than Leap Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision BioSciences$68.70M0.84$7.17M-$8.81-0.55
Leap TherapeuticsN/AN/A-$67.56M-$1.58-0.19

Leap Therapeutics has a net margin of 0.00% compared to Precision BioSciences' net margin of -6,205.79%. Precision BioSciences' return on equity of -176.47% beat Leap Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision BioSciences-6,205.79% -176.47% -69.05%
Leap Therapeutics N/A -237.65%-155.38%

In the previous week, Precision BioSciences' average media sentiment score of 1.02 beat Leap Therapeutics' score of 0.00 indicating that Precision BioSciences is being referred to more favorably in the media.

Company Overall Sentiment
Precision BioSciences Positive
Leap Therapeutics Neutral

Summary

Precision BioSciences beats Leap Therapeutics on 9 of the 14 factors compared between the two stocks.

Get Leap Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LPTX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LPTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LPTX vs. The Competition

MetricLeap TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$12.75M$3.16B$5.76B$10.50B
Dividend YieldN/A2.36%5.53%4.57%
P/E Ratio-0.1921.0475.9626.62
Price / SalesN/A252.06473.7891.77
Price / CashN/A46.3537.4661.85
Price / Book0.329.7813.486.45
Net Income-$67.56M-$52.73M$3.29B$271.57M
7 Day Performance-5.59%3.16%1.83%2.61%
1 Month Performance-0.81%4.69%4.00%7.28%
1 Year Performance-88.59%16.37%75.89%29.60%

Leap Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LPTX
Leap Therapeutics
2.3171 of 5 stars
$0.30
-4.0%
$3.38
+1,042.5%
-89.1%$12.75MN/A-0.1940Gap Down
DTIL
Precision BioSciences
4.3043 of 5 stars
$4.50
-2.4%
$47.00
+944.4%
-48.0%$54.34M$68.70M-0.51200
AADI
Aadi Bioscience
N/A$1.99
-1.0%
N/A-0.5%$49.15M$25.07M-0.8740
FGEN
FibroGen
4.235 of 5 stars
$11.84
-1.6%
$43.00
+263.2%
+28.7%$48.65M$29.62M-31.16570
PEPG
PepGen
2.5799 of 5 stars
$1.59
+7.4%
$7.25
+356.0%
-78.3%$48.54MN/A-0.5430
EGRX
Eagle Pharmaceuticals
1.3758 of 5 stars
$3.73
+16.0%
N/A-13.5%$48.38M$257.55M0.00100Gap Down
ANVS
Annovis Bio
1.935 of 5 stars
$2.42
-2.6%
$17.33
+617.7%
-72.2%$48.33MN/A-1.183
ACRV
Acrivon Therapeutics
2.8325 of 5 stars
$1.51
-0.7%
$15.50
+926.5%
-78.1%$47.81MN/A-0.6758
SCYX
SCYNEXIS
0.5957 of 5 stars
$1.10
-1.8%
N/A-27.7%$46.96M$3.75M-2.7560Positive News
RNXT
RenovoRx
2.5636 of 5 stars
$1.27
-0.8%
$7.50
+490.6%
+19.4%$46.91M$40K-3.346Gap Up
High Trading Volume
OTLK
Oncobiologics
2.0434 of 5 stars
$1.05
+1.0%
$9.60
+814.3%
-82.6%$46.20MN/A-1.8420News Coverage
Negative News
Analyst Forecast
Gap Down

Related Companies and Tools


This page (NASDAQ:LPTX) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners